A new Alzheimer’s treatment may help some patients, though researchers say more safety data is needed
[ad_1] A new study found that Eisai and Biogen’s experimental Alzheimer’s drug moderately reduced cognitive decline after a year and a half. Eisai’s 4523, +3.83% stock was up 1.7%% in…